Skip to main content
 CHANGE IN VISITATION GUIDELINES: Please read before visiting Rutgers Cancer Institute.

$10M Appropriation from State of NJ for Pediatric Cancer will Help Advance Research and Treatment

This legislation will support the establishment of the Pediatric Cancer Center at Rutgers Cancer Institute of New Jersey, which in partnership with RWJBarnabas Health, is a leader in pediatric cancer research and care. Read more


yellow ribbon and yellow connecting blocks spelling out HOPE

Cancer Immunology and Metabolism Center of Excellence

A generous donation of $25 million will support cancer research to help scientists better understand the human immune response to cancer and ultimately develop the foundation for new treatments or make existing therapies more effective. Learn more


Bringing research to life: From genetic implications to exploring the impact of self-cannibalization of cancer cells, scientists at Rutgers Cancer Institute work in concert with our physicians to translate cancer discoveries into today’s treatments.

female researcher working in lab

Research Overview

Female researcher working in the lab at Rutgers Cancer InstituteRutgers Cancer Institute of New Jersey's physician-scientists engage in translational research, transforming their laboratory discoveries into clinical practice, outsmarting cancer with science.

Rutgers Cancer Institute is a matrix style, basic, clinical and population research center as well as a consortium cancer center with Rutgers University and Princeton University leveraging the science of the state's cancer researchers through collaboration. Rutgers Cancer Institute of New Jersey is sharply focused on fulfilling the cancer research needs of the most densely populated and industry rich state in the nation.

Research is currently being conducted in areas including: behavioral science, precision medicine, systems biology, oncogenesis, tumor virology and immunology, autophagy, drug development and resistance, the relationship between cellular and genetic alterations and tumor development, cancer control and prevention, bioinformatics, and cancer genomics.

Rutgers Cancer Institute research programs and core facilities enhance and support the cancer research of more than 230 members at Rutgers University and Princeton University, including the Princeton branch of Ludwig Cancer Research. Based at Princeton University, the Ludwig Princeton Branch is dedicated to the study of cancer metabolism. Combined with Ludwig’s leadership in cancer epigenetics and immunotherapy, advances in cancer metabolism generated at the Ludwig Princeton Branch will inform new strategies for cancer prevention and treatment. The clinical translation of Branch discoveries will be conducted in the tri-state area, including in partnership with RWJBarnabas Health and Rutgers Cancer Institute.

Basic and Clinical Research Program Newsletters

Cancer Prevention and Control Program Newsletters

Rutgers Cancer Institute of New Jersey continues to expand its foundation of knowledge and the technical tools with which rapid advances can be made in understanding the mechanisms of cancer. Opportunities to manage the disease have increased and clinical research studies have yielded results that will have a profound effect in the prevention and treatment of many cancers.

Important Links

Rutgers Cancer Institute of New Jersey Research Programs

Rutgers Cancer Institute of New Jersey Shared Resources

Calendar of Research Program Meetings, Lectures and Other Events for Rutgers Cancer Institute of New Jersey Members

Acknowledging Cancer Center Support Grant (CCSG) Support for CINJ Pilot Award/New Investigator Funds or CCSG Supported CINJ Shared Resources

Collage of researchers working at Rutgers Cancer Institute in labs.